drugset / Trial / NCT04412837

The Use of Cannabinoid Patch for Knee Osteoarthritis

NCT04412837 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

This randomized, double-blind 2-arm parallel group study to determine the efficacy of a cannabinoid (CBD) patch on reducing pain in patients with knee osteoarthritis.

Timeline

Start
2022-10
Primary completion
2023-12
Completion
2024-02

Outcome

Outcome not reported

Stopped (Business): “Inadequate funding”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject CBD Unknown 35 mg Topical

Indications